Shuttle Pharmaceuticals Stock Price on April 23, 2024

SHPH Stock  USD 0.85  0.02  2.30%   
Below is the normalized historical share price chart for Shuttle Pharmaceuticals extending back to January 02, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Shuttle Pharmaceuticals stands at 0.85, as last reported on the 1st of December, with the highest price reaching 0.86 and the lowest price hitting 0.80 during the day.
IPO Date
31st of August 2022
200 Day MA
2.6008
50 Day MA
1.2123
Beta
0.74
 
Yuan Drop
 
Covid
If you're considering investing in Shuttle Stock, it is important to understand the factors that can impact its price. Shuttle Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.15, which indicates the firm had a -0.15% return per unit of risk over the last 3 months. Shuttle Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Shuttle Pharmaceuticals' Variance of 61.41, risk adjusted performance of (0.08), and Coefficient Of Variation of (877.28) to confirm the risk estimate we provide.
  
The current Common Stock is estimated to decrease to 152.95. The current Other Stockholder Equity is estimated to decrease to about 11.7 M. The current Price Earnings Ratio is estimated to decrease to -9.22. The current Price Book Value Ratio is estimated to decrease to 13.56. Shuttle Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1505

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsSHPH

Estimated Market Risk

 7.75
  actual daily
69
69% of assets are less volatile

Expected Return

 -1.17
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.15
  actual daily
0
Most of other assets perform better
Based on monthly moving average Shuttle Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Shuttle Pharmaceuticals by adding Shuttle Pharmaceuticals to a well-diversified portfolio.
Price Book
4.1571
Book Value
2.019
Enterprise Value
3.5 M
Enterprise Value Ebitda
(0.67)
Shares Float
1.4 M

Shuttle Pharmaceuticals Valuation on April 23, 2024

It is possible to determine the worth of Shuttle Pharmaceuticals on a given historical date. On April 23, 2024 Shuttle was worth 3.12 at the beginning of the trading date compared to the closed value of 3.1. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Shuttle Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Shuttle Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Shuttle Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Shuttle Pharmaceuticals' related companies.
 Open High Low Close Volume
  3.19    3.33    3.09    3.10    841.00  
04/23/2024
  3.12    3.12    2.96    3.10    2,971  
  2.97    3.44    2.97    3.11    2,239  
Backtest Shuttle Pharmaceuticals  |  Shuttle Pharmaceuticals History  |  Shuttle Pharmaceuticals Valuation   PreviousNext  
Open Value
3.12
3.1
Closing Value
26.37
Upside

Shuttle Pharmaceuticals Trading Date Momentum on April 23, 2024

On April 24 2024 Shuttle Pharmaceuticals was traded for  3.11  at the closing time. The top price for the day was 3.44  and the lowest listed price was  2.97 . The trading volume for the day was 2.2 K. The trading history from April 24, 2024 was a factor to the next trading day price growth. The trading price change against the next closing price was 0.32% . The trading price change against the current closing price is 8.39% .

Shuttle Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Shuttle Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Shuttle Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Shuttle financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Shuttle Pharmaceuticals Stock history

Shuttle Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Shuttle is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Shuttle Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Shuttle Pharmaceuticals stock prices may prove useful in developing a viable investing in Shuttle Pharmaceuticals
Last ReportedProjected for Next Year
Common Stock Shares Outstanding1.9 M1.8 M
Net Loss-2.8 M-2.7 M

Shuttle Pharmaceuticals Stock Technical Analysis

Shuttle Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Shuttle Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Shuttle Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Shuttle Pharmaceuticals Period Price Range

Low
December 1, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Shuttle Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Shuttle Pharmaceuticals December 1, 2024 Market Strength

Market strength indicators help investors to evaluate how Shuttle Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Shuttle Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Shuttle Pharmaceuticals stock market strength indicators, traders can identify Shuttle Pharmaceuticals entry and exit signals to maximize returns

Shuttle Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Shuttle Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Shuttle Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Shuttle to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Shuttle Stock analysis

When running Shuttle Pharmaceuticals' price analysis, check to measure Shuttle Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shuttle Pharmaceuticals is operating at the current time. Most of Shuttle Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Shuttle Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shuttle Pharmaceuticals' price. Additionally, you may evaluate how the addition of Shuttle Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance